Results 121 to 130 of about 20,052 (177)

A Review of the Pathological and Molecular Diagnosis of Primary Myelofibrosis. [PDF]

Cancers (Basel)
Shao R, Ryder C, Wang L, Zhang H, Moscinski L, Martin M, Shebes M, Li JY, Song J.   +8 more
europepmc   +1 more source

Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021. [PDF]

Ther Adv Hematol
Yu MS, Yu LH, Huang SH, Tsai TH, Lin AJ, Prchal JT, Chen MC, Lee KD.   +7 more
europepmc   +1 more source

Progression of carotid plaque burden in patients with polycythemia vera and essential thrombocythemia. [PDF]

Blood Res
Kwon SS, Jeong SY, Lee MY, Kim KH, Lee N, Won JH, Yoon SY.   +6 more
europepmc   +1 more source

Mitral Mass after Mitral Transcatheter Edge-to-edge Repair: Diagnostic Dilemma between Infective Endocarditis and Nonbacterial Thrombotic Endocarditis in a Patient with Malignancy.

J Cardiovasc Echogr
Bellina G, Casadei F, Musca F, Spanò FM, Moreo A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Essential Thrombocythemia

Seminars in Hematology, 2005
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philadelphia (Ph) chromosome-negative myeloproliferative disorders (MPDs) has recently been achieved. Unfortunately, the diagnosis of ET still relies on a set of exclusion criteria developed years ago, as recent advances have yet to ...
Guido, Finazzi, Claire, Harrison
openaire   +4 more sources

Management of Essential Thrombocythemia

Critical Reviews in Oncology/Hematology, 1999
3. Risk stratification of patients with ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.1. Bleeding and thrombosis in ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.2. Risk factors for major bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259 3.3. Risk factors for thrombosis. .
T, Barbui, G, Finazzi
openaire   +2 more sources

Essential thrombocythaemia

Best Practice & Research Clinical Haematology, 2003
Essential thrombocythaemia is a myeloproliferative disorder that results from the transformation of a multipotent haematopoietic progenitor. Its diagnosis can be challenging and its optimal management has been controversial, largely because of a virtual absence of randomised trials.
Claire N, Harrison, Anthony R, Green
openaire   +3 more sources

Stroke in essential thrombocythemia

Journal of the Neurological Sciences, 2014
Our aim was to assess the incidence and the special characteristics of stroke, as a severe complication of patients diagnosed with essential thrombocythemia (ET).A retrospective analysis was carried out on 102 patients with ET enrolled and analyzed from the period between 1999 and 2012. Patients with one or more strokes were selected.
Pósfai Éva, Marton Imelda, Szőke Anita, Borbényi Zita, Vécsei László, Csomor Angéla, Sas Katalin   +6 more
openaire   +3 more sources